Overview
Junling Li practices in Beijing, China. Li is rated as an Advanced expert by MediFind in the treatment of Squamous Cell Lung Carcinoma. Their top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Lung Adenocarcinoma.
Their clinical research consists of co-authoring 223 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Squamous Cell Lung Carcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- EGFR Positive Lung CancerLi isDistinguished. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaLi isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerLi isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- ParonychiaLi isDistinguished. Learn about Paronychia.
- Small Cell Lung Cancer (SCLC)
- Advanced
- Juvenile Dermatomyositis
- Squamous Cell Lung Carcinoma
- Experienced
- Acute Interstitial Pneumonia
- AgranulocytosisLi isExperienced. Learn about Agranulocytosis.
- Anal CancerLi isExperienced. Learn about Anal Cancer.
- Brain TumorLi isExperienced. Learn about Brain Tumor.
- CACH SyndromeLi isExperienced. Learn about CACH Syndrome.
- Coal Worker's Pneumoconiosis